Well, the health spending law has been passed. There's no doubt that it is huge and will cause a lot of "turbulence" as businesses adapt to the new environment. With turbulence comes opportunity.
Do you see investing opportunities resulting from the new law? Especially any ones that may be presently undervalued by the market?
The obvious first thought is insurance companies. An interesting article in today's WSJ puts it concisely
Regarding other health stocks (e.g. medical equipment manufacturers, drug companies, care providers)--it's also unclear. When price controls are put into place, we'd expect their margins to fall. But, when the waiting lists grow, people will still need to get their MRIs and lifesaving drugs. Will they buy these things in an unsubsidized private US market outside the new government controlled one? If the government responds by clamping down on such a market (as happened in Canada) will there be more medical tourism, maybe to the Caribbean where these businesses can function without government interference? There could be some intersting, high-risk startups. Maybe someone will buy a surplus USNS medical ship and park it 12 miles off the US coast and perform surgery?
Opportunites abound. I'm a believer in efficient markets, but that's not the same as believing that prices are always rational. Even if you love the new health spending bill, you can vote your convictions in the marketplace! Just short the stocks the companies driven to higher stock prices by the current fear/apprehension.
Do you see investing opportunities resulting from the new law? Especially any ones that may be presently undervalued by the market?
The obvious first thought is insurance companies. An interesting article in today's WSJ puts it concisely
So, according to this view, supply and demand will now cause health spending to significantly increase, and the only counterweight to this is government price controls. On the face of it, this puts insurers in a situation analogous to public utilities, and similar securities analysis techniques should probably guide us in determining the proper price for their stocks.[Regarding the position of health insurers]
But from the beginning, the industry was his [President Obama's] ally because he set out to solve its biggest problem—which is not the same as America's biggest problem.
We'll let Angela Braly, CEO of insurer WellPoint, take the story from here. She was recently hauled before Congress to justify her company's proposed 39% rate hike in California. She explained the source was two-fold: rising medical costs and healthier customers dropping their coverage, forcing the sick to pick up the tab.
Now this sounds like two problems, but for WellPoint and other insurers it's really only one problem. Once everyone is required by government mandate to buy insurance, the industry's survival is no longer threatened: It can just pass its skyrocketing costs along to customers. Once customers can no longer refuse to buy the industry's product, the problem of costs won't be fixed, but it no longer is the insurance industry's problem.
. . . .
For insurers, the check is in the mail: So watered down is the individual mandate that it must accelerate the industry's death spiral if not for the massive subsidies the government now has obliged itself to provide to keep the industry afloat and allow insurers to continue scalping their 15% off the top for serving as gatekeeper to a tax loophole.
When all is said and done, with unerring accuracy, ObamaCare has ended up doubling down on the system's existing perversities. The one thing it doesn't do (though it would be perfectly consistent with the Democratic goal of universal access) is incentivize a health-care marketplace based on competition in price and quality.
Regarding other health stocks (e.g. medical equipment manufacturers, drug companies, care providers)--it's also unclear. When price controls are put into place, we'd expect their margins to fall. But, when the waiting lists grow, people will still need to get their MRIs and lifesaving drugs. Will they buy these things in an unsubsidized private US market outside the new government controlled one? If the government responds by clamping down on such a market (as happened in Canada) will there be more medical tourism, maybe to the Caribbean where these businesses can function without government interference? There could be some intersting, high-risk startups. Maybe someone will buy a surplus USNS medical ship and park it 12 miles off the US coast and perform surgery?
Opportunites abound. I'm a believer in efficient markets, but that's not the same as believing that prices are always rational. Even if you love the new health spending bill, you can vote your convictions in the marketplace! Just short the stocks the companies driven to higher stock prices by the current fear/apprehension.